Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study

Overview of attention for article published in Journal of Psychopharmacology, November 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 4 X users

reddit: 3 Redditors
guideline: 1 clinical guideline source
bluesky: 1 Bluesky user

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,106 followers.

@a_dicander @frostsebaot @mainvolume @beckmansasikter What 😵‍💫 Genuint vettvilligt konstaterande. Här har du roligare läsning. https://t.co/XhpCISw6Nd

RT @BellevueDoc: Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study https://t.…

Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study https://t.co/A0mEoulPcD

small RCT: In an outpatient cohort of OCD, the reductions in Y-BOCS scores were greater and dose-related for ketamine vs. fentanyl (p=0.031). Score changes were maximal at 1–2 h with a steady separation of scores out to 168 h https://t.co/tswnmQPh6A https…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.